These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 9195339)
1. Distortions of the DNA double helix induced by 1,3-trans-diamminedichloroplatinum(II)-intrastrand cross-link: an internal coordinate molecular modeling study. Prévost C; Boudvillain M; Beudaert P; Leng M; Lavery R; Vovelle F J Biomol Struct Dyn; 1997 Jun; 14(6):703-14. PubMed ID: 9195339 [TBL] [Abstract][Full Text] [Related]
2. DNase I footprinting of cis- or trans-diamminedichloroplatinum(II)-modified DNA. Schwartz A; Leng M J Mol Biol; 1994 Mar; 236(4):969-74. PubMed ID: 8120904 [TBL] [Abstract][Full Text] [Related]
3. NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. Gelasco A; Lippard SJ Biochemistry; 1998 Jun; 37(26):9230-9. PubMed ID: 9649303 [TBL] [Abstract][Full Text] [Related]
4. DNA conformational change produced by the site-specific interstrand cross-link of trans-diamminedichloroplatinum(II). Brabec V; Síp M; Leng M Biochemistry; 1993 Nov; 32(43):11676-81. PubMed ID: 8218235 [TBL] [Abstract][Full Text] [Related]
5. Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatin. Scheeff ED; Briggs JM; Howell SB Mol Pharmacol; 1999 Sep; 56(3):633-43. PubMed ID: 10462551 [TBL] [Abstract][Full Text] [Related]
6. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids. Lippert B Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842 [TBL] [Abstract][Full Text] [Related]
8. Conformational rearrangement of 1,2-d(GG) intrastrand cis-diammineplatinum crosslinked DNA is driven by counter-ion penetration within the minor groove of the modified site. Gantchev TG; Petkov PS; Hunting DJ J Mol Model; 2017 Sep; 23(10):278. PubMed ID: 28913561 [TBL] [Abstract][Full Text] [Related]
9. Marked dependence on carrier-ligand bulk but not on carrier-ligand chirality of the duplex versus single-strand forms of a DNA oligonucleotide with a series of G-Pt(II)-G intrastrand cross-links modeling cisplatin-DNA adducts. Beljanski V; Villanueva JM; Doetsch PW; Natile G; Marzilli LG J Am Chem Soc; 2005 Nov; 127(45):15833-42. PubMed ID: 16277526 [TBL] [Abstract][Full Text] [Related]
10. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts. Kasparkova J; Novakova O; Farrell N; Brabec V Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292 [TBL] [Abstract][Full Text] [Related]
11. Interstrand cross-links of cisplatin induce striking distortions in DNA. Malinge JM; Giraud-Panis MJ; Leng M J Inorg Biochem; 1999 Oct; 77(1-2):23-9. PubMed ID: 10626349 [TBL] [Abstract][Full Text] [Related]
12. DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA. Pilch DS; Dunham SU; Jamieson ER; Lippard SJ; Breslauer KJ J Mol Biol; 2000 Feb; 296(3):803-12. PubMed ID: 10677282 [TBL] [Abstract][Full Text] [Related]
13. Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex. Poklar N; Pilch DS; Lippard SJ; Redding EA; Dunham SU; Breslauer KJ Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7606-11. PubMed ID: 8755522 [TBL] [Abstract][Full Text] [Related]
14. Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies. Kaspárková J; Mellish KJ; Qu Y; Brabec V; Farrell N Biochemistry; 1996 Dec; 35(51):16705-13. PubMed ID: 8988007 [TBL] [Abstract][Full Text] [Related]
15. Origins of the distortions in the base pair step adjacent to platinum anticancer drug-DNA adducts. Fundamental NMR solution studies utilizing right-handed cross-link models having 5'- and 3'-flanking residues. Saad JS; Natile G; Marzilli LG J Am Chem Soc; 2009 Sep; 131(34):12314-24. PubMed ID: 19655752 [TBL] [Abstract][Full Text] [Related]
16. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins. Kane SA; Lippard SJ Biochemistry; 1996 Feb; 35(7):2180-8. PubMed ID: 8652559 [TBL] [Abstract][Full Text] [Related]
17. NMR solution structure of a DNA decamer containing an interstrand cross-link of the antitumor drug cis-diamminedichloroplatinum (II). Paquet F; Pérez C; Leng M; Lancelot G; Malinge JM J Biomol Struct Dyn; 1996 Aug; 14(1):67-77. PubMed ID: 8877563 [TBL] [Abstract][Full Text] [Related]
18. DNA double helix promotes a linkage isomerization reaction in trans-diamminedichloroplatinum(II)-modified DNA. Dalbiès R; Payet D; Leng M Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8147-51. PubMed ID: 8058771 [TBL] [Abstract][Full Text] [Related]
19. DNA bending and unwinding due to the major 1,2-GG intrastrand cross-link formed by antitumor cis-diamminedichloroplatinum(II) are flanking-base independent. Stehlikova K; Kostrhunova H; Kasparkova J; Brabec V Nucleic Acids Res; 2002 Jul; 30(13):2894-8. PubMed ID: 12087174 [TBL] [Abstract][Full Text] [Related]
20. Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent. Baruah H; Wright MW; Bierbach U Biochemistry; 2005 Apr; 44(16):6059-70. PubMed ID: 15835895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]